Summit Trail Advisors’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Buy
8,632
+825
+11% +$228K 0.03% 436
2025
Q4
$2.15M Buy
7,807
+1,132
+17% +$317K 0.04% 366
2025
Q3
$1.92M Sell
6,675
-2,087
-24% -$618K 0.03% 468
2025
Q2
$2.9M Buy
+8,762
New +$2.82M 0.05% 189
2024
Q4
Sell
-2,034
Closed -$705K 465
2024
Q3
$705K Buy
2,034
+357
+21% +$123K 0.02% 326
2024
Q2
$554K Buy
1,677
+110
+7% +$37.9K 0.01% 351
2024
Q1
$569K Buy
1,567
+204
+15% +$67.2K 0.02% 311
2023
Q4
$408K Sell
1,363
-304
-18% -$88.8K 0.01% 321
2023
Q3
$477K Buy
1,667
+251
+18% +$71.6K 0.02% 283
2023
Q2
$397K Buy
1,416
+606
+75% +$158K 0.02% 309
2023
Q1
$207K Buy
+810
New +$236K 0.01% 384
2018
Q1
Sell
-840
Closed -$183K 657
2017
Q4
$183K Buy
+840
New +$167K 0.02% 450

Other funds holding CI

Summit Trail Advisors's CI Position: Q1 2026 in Review

Summit Trail Advisors increased its Cigna (CI) stake by 11% in Q1 2026, buying an estimated $228K and bringing the position to 8,632 shares worth $2.3M. The position accounts for 0.03% of the portfolio, ranked #436.

Summit Trail Advisors first reported a position in CI in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.9M in Q2 2025. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Summit Trail Advisors held 8,632 shares of Cigna worth $2.3M as of Q1 2026.
  • Summit Trail Advisors bought 825 Cigna shares in Q1 2026, an estimated $228K.
  • Cigna made up 0.03% of Summit Trail Advisors's portfolio in Q1 2026, its #436 holding.
  • Summit Trail Advisors first reported a position in Cigna in Q4 2017 and has held it in 12 quarters since.
  • Summit Trail Advisors's Cigna position peaked at $2.9M in Q2 2025.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.